Akoya Biosciences Inc Forecast, price target & analysts
Akoya Biosciences Inc Target price 2025 - Analyst rating & recommendation
Akoya Biosciences Inc Classifications & Recommendation:
Akoya Biosciences Inc Price Target
| Target Price | $1.42 |
| Price | $1.23 |
| Potential |
15.24%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Akoya Biosciences Inc 2026 .
The average Akoya Biosciences Inc target price is $1.42.
This is
15.24%
register free of charge
$1.80
46.34%
register free of charge
$1.08
12.20%
register free of charge
|
|
| A rating was issued by 5 analysts: 0 Analysts recommend Akoya Biosciences Inc to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Akoya Biosciences Inc stock has an average upside potential 2026 of
15.24%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 81.67 | 84.46 |
| 15.48% | 3.42% | |
| EBITDA Margin | -49.19% | -36.24% |
| 4.18% | 26.32% | |
| Net Margin | -67.80% | -44.26% |
| 3.46% | 34.72% |
5 Analysts have issued a sales forecast Akoya Biosciences Inc 2025 . The average Akoya Biosciences Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Akoya Biosciences Inc EBITDA forecast 2025. The average Akoya Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Akoya Biosciences Inc 2025 . The average Akoya Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.12 | -0.75 |
| 21.68% | 33.04% | |
| P/E | negative | |
| EV/Sales | 1.34 |
1 Analysts have issued a Akoya Biosciences Inc forecast for earnings per share. The average Akoya Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
Akoya Biosciences Inc...
Current Akoya Biosciences Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 19 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 14 2025 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 19 2024 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 19 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 14 2025 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 19 2024 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 15 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
